Survivin as a Preferential Target for Cancer Therapy

by Mahsa Mobahat, Aru Narendran, Karl Riabowol
Published 2014-02-01

ING3 promotes prostate cancer growth by activating the androgen receptor

by Arash Nabbi, Urszula L. McClurg, Subhash Thalappilly, Amal Almami, Mahsa Mobahat, Tarek A. Bismar, Olivier Binda, Karl T. Riabowol
Published 2017-05-01